# Lattice Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lattice-medical

- Industry: Medical Devices & Equipment
- Headquarters: Loos, France
- Website: www.lattice-medical.com
- Total disclosed funding: $50M
- Latest round: Series B (Oct 27, 2025)
- Investors on record: 5

## About

Based in France, Lattice Medical SAS is a medical technology company focusing on innovative solutions for tissue regeneration and bioprosthetic applications, enhancing recovery for patients undergoing reconstructive surgery.Lattice Medical SAS, founded in 2017 in Loos, France, specializes in medical devices for tissue regeneration. The company has not undergone significant changes in its business strategy. The founder's previous ventures are not publicly documented. Lattice Medical recently raised EUR 43.00 mn in Series B funding on October 27, 2025, with investors including Blast.Club and CAPTECH Sante, marking its third funding deal which has contributed to a total amount raised of EUR 43.00 mn.Lattice Medical specializes in the development of innovative medical devices focused on tissue regeneration and bioprosthetic solutions. Their primary offerings include MATTISSE, a 3D-printed, resorbable breast prosthesis designed to enhance post-cancer reconstruction, and RODIN, a matrix that facilitates the regeneration of subcutaneous tissue. Both products employ advanced biomaterials to address critical needs in soft tissue restoration, thereby improving the quality of care for patients undergoing reconstructive surgery. Targeting healthcare professionals and institutions, Lattice Medical aims to serve markets in Europe and North America, collaborating with hospitals, clinics, and medical practitioners involved in breast cancer reconstruction and tissue engineering.The revenue structure for Lattice Medical is primarily based on direct sales of its medical devices to healthcare providers and institutions involved in reconstructive surgery. The company engages in business-to-business transactions, where hospitals and clinics purchase MATTISSE and RODIN through established procurement channels. Revenue is generated from the sales of these flagship products, which are incorporated into surgical procedures aimed at improving patient outcomes. Lattice Medical may also explore partnerships or collaborations with medical institutions for clinical trials and studies, enhancing their product development and market reach. The company’s focus on innovation and quality aims to position it favorably within the competitive landscape of medical devices.In October 2025, Lattice Medical SAS raised EUR 45.00 mn in Series B funding, led by new investor SPI Fund, with participation from Blast.Club and Sprim Ventures. The funding will be utilized to complete clinical development of its 3D-printed breast implant and expand production capacity. Lattice Medical plans to launch new products designed specifically for reconstructive surgery and aims to enter additional markets in Europe and North America by 2026, thereby increasing patient access to their innovative solutions.

## Funding rounds

- Series B, Oct 27, 2025, $50M — Nord France Amorcage, Sprim Ventures, Blast.Club, European Innovation Council, CAPTECH Sante

## Investors

- Nord France Amorcage — Series B
- Sprim Ventures (https://capitalatlas.ai/funds/sprim-ventures) — Series B
- Blast.Club (https://capitalatlas.ai/funds/blast-club) — Series B
- European Innovation Council (https://capitalatlas.ai/funds/european-innovation-council) — Series B
- CAPTECH Sante — Series B